Last reviewed · How we verify
Macular edema due to diabetes mellitus
Approved treatments
- Vabysmo · Roche
Vabysmo works by blocking the activity of a protein called vascular endothelial growth factor A. - Eylea · Texas Retina Associates
- VABYSMO · GENENTECH INC
- Lucentis · Santen Inc.
- Beovu · Novartis
Beovu works by binding to vascular endothelial growth factor A (VEGF-A), preventing its interaction with its receptor and reducing vascular permeability and inflammation. - Vegf Trap · Regeneron
- Beovu · Novartis Pharmaceuticals
- BYOOVIZ · SAMSUNG BIOEPIS CO LTD
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Macular edema due to diabetes mellitus patent landscape — cliff calendar, originator estates, attackable patents
- Macular edema due to diabetes mellitus treatment landscape brief
- Macular edema due to diabetes mellitus treatment updates RSS
Frequently asked questions about Macular edema due to diabetes mellitus
What drugs treat Macular edema due to diabetes mellitus?
Tracked treatments include Vabysmo, Eylea, VABYSMO, Lucentis, Beovu, Vegf Trap, BYOOVIZ.
What is the treatment for Macular edema due to diabetes mellitus?
Standard treatment for Macular edema due to diabetes mellitus includes Vabysmo, Eylea, VABYSMO, Lucentis, Beovu. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Macular edema due to diabetes mellitus patent cliff · Macular edema due to diabetes mellitus CI report
- Treatment: Vabysmo · Roche
- Treatment: Eylea · Texas Retina Associates
- Treatment: VABYSMO · GENENTECH INC
- Treatment: Lucentis · Santen Inc.
- Treatment: Beovu · Novartis
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing